Recruiting Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease NCT07566494 Conditions Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
